Histology
Non-Small Cell Carcinoma
CI-CAN-00001292Explore in graph →
1,752 active trials47 approved drugs589 evidence items
- NCIt
- C65151
Loading cancer entity…
Loading cancer entity…
Histology
CI-CAN-00001292Explore in graph →
Clinical trials
6,757 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,046)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01282437 | Prophylactic Cranial Irradiation (PCI) vs Observation in Stage III NSCLC(NVALT11) | completed | Phase 3 | 315 | Maastricht Radiation OncologyOTHER | 1 | Apr 10, 2015 | clinicaltrials |
| NCT00254891 | Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer | terminated | Phase 3 | 828 | PfizerINDUSTRY | 26 | Mar 30, 2015 | clinicaltrials |
| NCT00254904 | Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLC | terminated | Phase 3 | 839 | PfizerINDUSTRY | 24 | Mar 30, 2015 | clinicaltrials |
| NCT02387086 | Gefitinib Combined With Thalidomide to Treat NSCLC | unknown | Phase 2 / Phase 3 | 380 | Bai JunOTHER | 0 | Mar 12, 2015 | clinicaltrials |
| NCT01342965 | A Study of Erlotinib (Tarceva) Versus Gemcitabine/Cisplatin as First-line Treatment in Patients With Non-small Cell Lung Cancer With EGFR Mutations | completed | Phase 3 | 217 | Hoffmann-La RocheINDUSTRY | 3 | Feb 24, 2015 | clinicaltrials |
| NCT00556322 | A Study of Tarceva (Erlotinib) and Standard of Care Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 424 | Hoffmann-La RocheINDUSTRY | 27 | Feb 23, 2015 | clinicaltrials |
| NCT00535275 | NSCLC Relapse Therapy After Surgery and Peri-operative Chemotherapy | terminated | Phase 3 | 88 | Intergroupe Francophone de Cancerologie ThoraciqueOTHER | 1 | Feb 16, 2015 | clinicaltrials |
| NCT00633568 | Randomised Study of Concomitant Radiochemotherapy in Non-small Cell Lung Cancer | terminated | Phase 3 | 125 | European Lung Cancer Working PartyOTHER | 4 | Feb 12, 2015 | clinicaltrials |
| NCT02140333 | Erlotinib 100mg or 150mg in Treating EGFR Mutated NSCLC | unknown | Phase 3 | 220 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Feb 12, 2015 | clinicaltrials |
| NCT00556712 | A Study of Tarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 889 | Hoffmann-La RocheINDUSTRY | 28 | Feb 11, 2015 | clinicaltrials |
| NCT02338011 | Comparator-Controlled Study for EGFR(+) Patients With Multiple BMs From NSCLC (BROKE) (EGFR-epidermal Growth Factor Receptor;BM-brain Metastases)(EGFR) | unknown | Phase 2 / Phase 3 | 210 | Shanghai Chest HospitalOTHER | 1 | Jan 26, 2015 | clinicaltrials |
| NCT01046383 | Effect of IMN1207 Versus Casein on Weight Loss, Survival and Quality of Life in Non-small Cell Lung Cancer Patients | terminated | Phase 3 | 16 | Immunotec Inc.INDUSTRY | 1 | Jan 21, 2015 | clinicaltrials |
| NCT00718315 | A Study of Verutex (Fusidic Acid), Eritex (Erythromycin) and Fisiogel in the Management of Tarceva-Associated Rash. | completed | Phase 3 | 201 | Hoffmann-La RocheINDUSTRY | 1 | Jan 15, 2015 | clinicaltrials |
| NCT00049543 | Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery | completed | Phase 3 | 503 | National Cancer Institute (NCI)NIH | 1 | Jan 1, 2015 | clinicaltrials |
| NCT00102804 | Pemetrexed and Best Supportive Care Versus Placebo and Best Supportive Care in Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 663 | Eli Lilly and CompanyINDUSTRY | 20 | Dec 29, 2014 | clinicaltrials |
| NCT01761747 | Ponatinib for Squamous Cell Lung and Head and Neck Cancers | terminated | Phase 2 / Phase 3 | 3 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 23, 2014 | clinicaltrials |
| NCT00874419 | Erlotinib Versus Gemcitabine/Carboplatin in Chemo-naive Stage IIIB/IV Non-Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Exon 19 or 21 Mutation(ML20981) | completed | Phase 3 | 165 | Tongji UniversityOTHER | 1 | Sep 25, 2014 | clinicaltrials |
| NCT00321334 | Survival Study of Docetaxel and Carboplatin as Neo-Adjuvant Vs Adjuvant Chemotherapy in Early Stage NSLC | completed | Phase 3 | 410 | Chinese Society of Lung CancerOTHER | 1 | Aug 6, 2014 | clinicaltrials |
| NCT00415818 | Immunotherapy With TG4010 in Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 / Phase 3 | 148 | TransgeneINDUSTRY | 4 | Jul 16, 2014 | clinicaltrials |
| NCT00499109 | Phase III of RRM1 & ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLC | completed | Phase 3 | 275 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 3 | Jul 9, 2014 | clinicaltrials |
| NCT00148798 | Study of Cisplatin/Vinorelbine +/- Cetuximab as First-line Treatment of Advanced Non Small Cell Lung Cancer (FLEX)(FLEX) | completed | Phase 3 | 1,861 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 28 | Jun 25, 2014 | clinicaltrials |
| NCT00907504 | Study Of The Effect Of CP-751,871 In Combination With Gemcitabine And Cisplatin In Patients With Advanced Non-Small Cell Lung Cancer(ADVIGO1017) | withdrawn | Phase 3 | 0 | PfizerINDUSTRY | 0 | Jun 17, 2014 | clinicaltrials |
| NCT00003869 | Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer | completed | Phase 3 | 186 | National Cancer Institute (NCI)NIH | 1 | May 20, 2014 | clinicaltrials |
| NCT00820755 | Trial With Cetuximab in Maintenance Therapy After Platinum Based Chemotherapy in First Line Treatment of Non-small Cell Lung Cancer (NSCLC)(NEXT) | completed | Phase 3 | 583 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 1 | May 5, 2014 | clinicaltrials |
| NCT00091663 | A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 5,000 | Genentech, Inc.INDUSTRY | 1 | Mar 4, 2014 | clinicaltrials |
| NCT01040780 | Safety and Efficacy Study of Icotinb in Non-small Cell Lung Cancer (NSCLC) Patients(ICOGEN) | completed | Phase 3 | 399 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Feb 14, 2014 | clinicaltrials |
| NCT02058433 | Safety Study of Individual Paclitaxel Dose Adjustment Based on Pharmacokinetics in Non-Small Cell Lung Cancer (NSCLC) | unknown | Phase 3 | 140 | Caicun ZhouOTHER | 1 | Feb 10, 2014 | clinicaltrials |
| NCT00390806 | Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer | completed | Phase 3 | 472 | GlaxoSmithKlineINDUSTRY | 6 | Jan 20, 2014 | clinicaltrials |
| NCT00596830 | Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology | terminated | Phase 3 | 681 | PfizerINDUSTRY | 26 | Jan 13, 2014 | clinicaltrials |
| NCT02011997 | Comparison of cVATS Segmentectomy Versus Lobectomy for Lung Adenocarcinoma in Situ and With Microinvasion(cVATS) | unknown | Phase 3 | 500 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Dec 16, 2013 | clinicaltrials |
| NCT01005680 | A Study Comparing Two Different Chemotherapy Types in Chinese Patients With Advanced Non Small Cell Lung Cancer | completed | Phase 3 | 256 | Eli Lilly and CompanyINDUSTRY | 1 | Dec 13, 2013 | clinicaltrials |
| NCT01287962 | Apatinib in the Treatment of Advanced Non-squamous Non-small Cell Lung Cancer | unknown | Phase 3 | 480 | Sun Yat-sen UniversityOTHER | 1 | Dec 9, 2013 | clinicaltrials |
| NCT02001896 | Erlotinib Intercalated With Chemotherapy Versus Erlotinib as First Line Treatment in Stage IIIB/IV NSCLC Patients With EGFR Mutation | unknown | Phase 3 | 60 | Xinjiang Medical UniversityOTHER | 1 | Dec 5, 2013 | clinicaltrials |
| NCT02001168 | Comparison of Postoperative Adjuvant Chemotherapy With/Without Rh-endostatin on Non-small Cell Lung Cancer in PhaseⅠB | unknown | Phase 3 | 392 | Xinjiang Medical UniversityOTHER | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00322452 | First Line IRESSA™ Versus Carboplatin/Paclitaxel in Asia(IPASS) | completed | Phase 3 | 1,329 | AstraZenecaINDUSTRY | 9 | Nov 7, 2013 | clinicaltrials |
| NCT01977209 | Gossypol Combined With Docetaxel and Cisplatin Scheme in Advanced Non Small-cell Lung Cancers With APE1 High Expression(GTCA) | unknown | Phase 3 | 204 | Third Military Medical UniversityOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT01528488 | Prophylactic EVOZAC® Calming Skin Spray for EGFR-TKIs Associated Rash Eruption in NSCLC | completed | Phase 2 / Phase 3 | 118 | Sun Yat-sen UniversityOTHER | 1 | Nov 5, 2013 | clinicaltrials |
| NCT00457392 | A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone | completed | Phase 3 | 960 | PfizerINDUSTRY | 26 | Oct 29, 2013 | clinicaltrials |
| NCT00298415 | Chemotherapy of Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC) | completed | Phase 3 | 451 | Intergroupe Francophone de Cancerologie ThoraciqueOTHER | 1 | Oct 25, 2013 | clinicaltrials |
| NCT01947062 | Metronomic Cyclophosphamide in Combination With Standard Chemotherapy for Squamous Cell Lung Carcinoma | unknown | Phase 3 | 60 | Swami Rama Cancer Hospital and Research InstituteINDUSTRY | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00864331 | Optimization of Treatment of Advanced Nonsmall Cell Lung Cancer Using Radiotherapy and Chemotherapy | completed | Phase 3 | 251 | International Atomic Energy AgencyOTHER_GOV | 13 | Aug 7, 2013 | clinicaltrials |
| NCT00673049 | Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer(NSCLC) | terminated | Phase 3 | 583 | PfizerINDUSTRY | 27 | Jul 24, 2013 | clinicaltrials |
| NCT00002852 | Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer | completed | Phase 3 | 500 | National Cancer Institute (NCI)NIH | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00771563 | Enoxaparin Low Molecular Weight Heparin (LMWH) in Advanced Non Small Cell Lung Cancer: Effect on Survival and Symptom Control in Patients Undergoing First Line Chemotherapy (SYRINGES)(SYRINGES) | completed | Phase 3 | 104 | University Hospital, AntwerpOTHER | 1 | Jun 28, 2013 | clinicaltrials |
| NCT00050973 | Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer | completed | Phase 3 | 623 | Eisai Inc.INDUSTRY | 11 | May 14, 2013 | clinicaltrials |
| NCT01836575 | Alimta® Versus Its Combination With Carboplatin in Advanced Non-small-cell Lung Cancer in Patients Performance Status 2(PS2) | completed | Phase 3 | 228 | Instituto Nacional de Cancer, BrazilOTHER_GOV | 2 | Apr 22, 2013 | clinicaltrials |
| NCT00049998 | Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung Cancer | completed | Phase 3 | 760 | GlaxoSmithKlineINDUSTRY | 31 | Mar 4, 2013 | clinicaltrials |
| NCT01802021 | Effect of Astragalus-based Formula: Qingshu-Yiqi-Tang on Modulating Immune Alterations in Lung Cancer Patients(QSYQT) | unknown | Phase 2 / Phase 3 | 120 | Chang Gung Memorial HospitalOTHER | 1 | Mar 1, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Apr 10, 2015source: clinicaltrials